The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Savings Plans 2014
For 5 years, from 2008 to 2012, Invest for children has made 23 employees with Down’s Syndrome beneficiaries of a savings plan contracted at La Caixa. This is a pioneer…
see project 
